Prognostic value of immunohistochemical staining for H3K27me3 and EZH2 in astrocytoma, IDH-mutantShumpei Onishi, Nobutaka Horie|Journal of Neuro-Oncology|2024Cited by 2
PRMT5 inhibition sensitizes glioblastoma tumor models to temozolomideShumpei Onishi, Yeshavanth Banasavadi‐Siddegowda, Kimberly Rivera-Caraballo et al.|Research Square|2025Cited by 1
DDDR-02. PRMT5 inhibition sensitizes glioblastoma tumor models to temozolomideShumpei Onishi, Yeshavanth Banasavadi‐Siddegowda, Sridharan Jayamohan et al.|Neuro-Oncology|2025Cited by 1